GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 812 filers reported holding GLAXOSMITHKLINE PLC in Q4 2020. The put-call ratio across all filers is 1.32 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $2,297,000 | +15.1% | 52,490 | +14.6% | 0.30% | +29.6% |
| Q1 2022 | $1,995,000 | -0.1% | 45,808 | +1.1% | 0.23% | -0.4% |
| Q4 2021 | $1,997,000 | +15.4% | 45,290 | +0.0% | 0.23% | +1.8% |
| Q3 2021 | $1,730,000 | -8.0% | 45,276 | -4.1% | 0.23% | -13.0% |
| Q2 2021 | $1,880,000 | +17.1% | 47,205 | +4.9% | 0.26% | +7.0% |
| Q1 2021 | $1,606,000 | -5.3% | 44,996 | -2.3% | 0.24% | -15.0% |
| Q4 2020 | $1,695,000 | +2.2% | 46,064 | +4.6% | 0.29% | -11.1% |
| Q3 2020 | $1,658,000 | -1.8% | 44,057 | +6.4% | 0.32% | -11.3% |
| Q2 2020 | $1,689,000 | +24.5% | 41,401 | +15.6% | 0.36% | +2.2% |
| Q1 2020 | $1,357,000 | -19.4% | 35,818 | +0.0% | 0.36% | +0.8% |
| Q4 2019 | $1,683,000 | +12.0% | 35,813 | +1.7% | 0.35% | +0.6% |
| Q3 2019 | $1,503,000 | +12.0% | 35,219 | +5.0% | 0.35% | +7.7% |
| Q2 2019 | $1,342,000 | -4.1% | 33,544 | +0.1% | 0.33% | -8.9% |
| Q1 2019 | $1,400,000 | +11.5% | 33,494 | +5.0% | 0.36% | +0.3% |
| Q4 2018 | $1,256,000 | -41.2% | 31,901 | -39.9% | 0.36% | +22.3% |
| Q3 2018 | $2,136,000 | +109.2% | 53,108 | +109.6% | 0.29% | +1.4% |
| Q2 2018 | $1,021,000 | +12.8% | 25,339 | +9.4% | 0.29% | +7.5% |
| Q1 2018 | $905,000 | +19.1% | 23,164 | +8.2% | 0.27% | +19.6% |
| Q4 2017 | $760,000 | -32.8% | 21,414 | -23.1% | 0.22% | -40.7% |
| Q3 2017 | $1,131,000 | -4.0% | 27,849 | +1.9% | 0.38% | -9.6% |
| Q2 2017 | $1,178,000 | +4.7% | 27,324 | +2.4% | 0.42% | +3.5% |
| Q1 2017 | $1,125,000 | +10.5% | 26,694 | +0.9% | 0.40% | +2.0% |
| Q4 2016 | $1,018,000 | -11.2% | 26,444 | -0.4% | 0.40% | -11.6% |
| Q3 2016 | $1,146,000 | +2.4% | 26,559 | +2.9% | 0.45% | -2.2% |
| Q2 2016 | $1,119,000 | +9.3% | 25,809 | +2.2% | 0.46% | +6.8% |
| Q1 2016 | $1,024,000 | -1.8% | 25,244 | -2.3% | 0.43% | -15.0% |
| Q4 2015 | $1,043,000 | +7.3% | 25,844 | +2.2% | 0.50% | +1.2% |
| Q3 2015 | $972,000 | -5.2% | 25,279 | +2.7% | 0.50% | +1.4% |
| Q2 2015 | $1,025,000 | -4.7% | 24,604 | +5.6% | 0.49% | -3.7% |
| Q1 2015 | $1,075,000 | +10.6% | 23,289 | +2.4% | 0.51% | -0.6% |
| Q4 2014 | $972,000 | +7.2% | 22,739 | +15.3% | 0.51% | -3.9% |
| Q3 2014 | $907,000 | +19.2% | 19,719 | +38.5% | 0.54% | +18.6% |
| Q2 2014 | $761,000 | +11.4% | 14,234 | +11.4% | 0.45% | +7.9% |
| Q1 2014 | $683,000 | +5.6% | 12,783 | +5.4% | 0.42% | -3.0% |
| Q4 2013 | $647,000 | – | 12,123 | – | 0.43% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Healthcare Value Capital, LLC | 100,000 | $3,680,000 | 12.40% |
| Black Creek Investment Management Inc. | 7,443,061 | $273,905,000 | 8.54% |
| KAHN BROTHERS GROUP INC | 1,281,924 | $47,174,803,000 | 8.23% |
| Camber Capital Management LP | 3,500,000 | $128,800,000 | 4.52% |
| Eversept Partners, LP | 946,581 | $35,196,522 | 4.13% |
| EQUITY INVESTMENT CORP | 2,321,164 | $85,419,000 | 3.98% |
| Galibier Capital Management Ltd. | 575,741 | $21,187,000 | 3.66% |
| Keystone Financial Planning, Inc. | 217,399 | $8,000,000 | 3.32% |
| CLIFFORD CAPITAL PARTNERS LLC | 217,817 | $8,016,000 | 3.14% |
| CLARK ESTATES INC/NY | 485,000 | $17,848,000 | 2.52% |